There's now a dedicated centre in Sharjah to receive volunteers for the third phase of trials for a COVID-19 vaccine.
The Ministry of Health and Prevention (MoHAP)'s Al Qarayen Health Centre is the first facility outside Abu Dhabi to register, screen and test participants.
It can handle more than 500 people a day and is open to residents of Sharjah, Dubai and the Northern Emirates.
Thousands of volunteers have already registered for the trial programme which kicked off in Abu Dhabi last month.
"We are optimistic about achieving promising results that would support the global efforts being made to develop the vaccine," said Abdul Rahman Mohammed Al Owais, Minister of Health & Prevention.
"Expanding the geographical scope of the #4Humanity campaign to include all emirates aims to enhance the results of clinical trials and ensure the safety and effectiveness of the vaccine on a larger segment of individuals."
G42 Healthcare is managing the overall clinical trial process under the supervision of the Department of Health Abu Dhabi and in coordination with Abu Dhabi Health Services (SEHA).
The inactivated vaccine used in the trials has been developed by China's Sinopharm CNBG, and has shown promising results during the earlier Phase I and Phase II trials.


UAE fines 42 domestic worker recruitment firms for violating rules
Dubai's RTA expands e-bike delivery service to seven new areas
Sharjah Charity sends food aid to Bangladesh flood victims
UAE condemns Israeli settler attacks in occupied West Bank
President commends global humanitarian efforts of UAE Search and Rescue Team
UAE discusses regional developments with Qatar, Oman
Dubai Police launch doorstep service for lost-and-found items
UAE expresses solidarity with France over wildfires
